ArticlePloS one2015

Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.

Priscilla F McAuliffe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.